Julie
is a real patient
with RA, performing
an everyday activity...
Welcome to ACTEMRA World
This site is intended for healthcare professionals and is an extensive resource site for healthcare professionals with an interest in rheumatoid arthritis (RA) and its treatment with ACTEMRA® (tocilizumab), a first-in-class agent with a novel mechanism of action that targets the interleukin-6 (IL-6) receptor.
The product is known as RoACTEMRA in the EU and Mexico and as ACTEMRA in other countries.
This site contains, amongst other things, information on the mechanisms of action of ACTEMRA, guides to dosing and administration, and efficacy and safety data from key Phase III clinical trials. There is also a useful resource section containing a range of downloadable materials on RA and ACTEMRA.
About ACTEMRA
This section contains detailed scientific and medical information on ACTEMRA, including the mechanisms of action, dosage and administration details, and safety and efficacy information from key clinical trials. More...
Resources
Within this section there is a wealth of useful information and practical items relating to the treatment of rheumatoid arthritis (RA) and the use of ACTEMRA. As well as printable charts and brochures, there will be soon links to journals, congress materials and highlights and general information on RA available. More...
- © 2012 Roche Hong Kong Limited
This website contains information on products which is targeted to a wide range
of audiences and could contain product details or information otherwise not accessible or valid in
your country.
Please be aware that we do not take any responsibility for accessing such information which may
not comply with any legal process, regulation, registration or usage in the country of your origin.
Remark: This statement has been translated into Chinese. In case of inconsistency between the
English and Chinese versions, the English version shall prevail.